Ireland· IE-PA-EU/1/96/027/003
Hycamtin 4 mg powder for concentrate for solution for infusion
A topotecan product containing topotecan hydrochloride, registered in Ireland by Sandoz Pharmaceuticals d.d.. The same ATC class is registered in 4 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Topotecan is registered in 4 of 19 countries.
Countries holding a registration under ATC L01XX17 (topotecan), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Topotecan · ATC L01XX17
4 / 19 countries
- Belgiumprice
- Ireland
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Topotecan hydrochloride
- Manufacturer
- Sandoz Pharmaceuticals d.d.
- Country
- Ireland (IE)
- ATC code
- L01XX17
- ATC class
- Topotecan
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/96/027/003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
348 interactions on record for topotecan.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Topotecan · interactions on record
348 records
- 31 severe
- 277 moderate
- 16 minor
- 24 info
Most severe, free to view
- CisplatinL01XA01severe
- CarboplatinL01XA02severe
- OxaliplatinL01XA03severe
- RolapitantA04AD14moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Topotecan in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEvotopinBeecham Group plc.
- United KingdomHycamtin 4mg powder for concentrate for solution for infusion vialsNovartis Pharmaceuticals UK Ltd
- BelgiumHycamtin 4 mgSandoz Pharmaceuticals
- SwedenHycamtin 4 mg Pulver till koncentrat till infusionsvätska, lösningSandoz Pharmaceuticals d.d.
- CzechiaHYCAMTINSandoz Pharmaceuticals d.d., Ljubljana
- SpainHYCAMTIN 4 mg POLVO CONCENTRADO PARA SOLUCION PARA PERFUSIONSandoz Pharmaceuticals D.D.
- IcelandHycamtinSandoz Pharmaceuticals d.d.
- PolandHycamtinSandoz Pharmaceuticals d.d.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Topotecan Accord, Topotecan Ebewe
- Belgium · Topotecan Accord Healthcare
- Bulgaria · Топотекан Акорд
- Cyprus · Topotecan Accord, Topotecan Venus
- Czechia · Topotecan Accord
- Germany · Topotecan Accord, Topotecan Hexal
- Denmark · Topotecan "ebewe", Topotecan Accord
- Estonia · Topotecan Accord
- Spain · Topotecán Accord
- Finland · Topotecan Accord, Topotecan Ebewe
- France · Topotecane Accord
- United Kingdom (Northern Ireland) · Topotecan Accord Healthcare, Topotecan Sandoz
- Greece · Topocan, Topotecan Accord
- Croatia · Topotekan Alpha-Medical
- Hungary · Topotecan Accord
- Iceland · Hycamtin, Potactasol
- Italy · Topotecan Ahcl
- Liechtenstein · Hycamtin, Hycamtin 4 Mg Powder For Concentrate For Solution For Infusion
- Lithuania · Topotecan Accord
- Luxembourg · Topotecan Accord Healthcare
- Latvia · Topotecan Ahcl
- Netherlands · Topotecan Accord, Topotecan Hikma
- Norway · Hycamtin, Potactasol
- Poland · Topotecanum Accord
- Portugal · Topotecano Accord, Topotecano Azevedos
- Romania · Topotecan Accord
- Sweden · Topotecan Accord, Topotecan Ebewe
- Slovenia · Topotekan Accord
- Slovakia · Topotecan Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6dcaa09a-a5f2-46da-a9a0-aac0967c932f GET /v1/drugs/6dcaa09a-a5f2-46da-a9a0-aac0967c932f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for concentrate for solution for infusion",
"routes": null,
"source": "hpra",
"atc_all": [
"L01XX",
"L01XX17"
],
"strength": null,
"pa_number": "EU/1/96/027/003",
"substances": [
"Topotecan hydrochloride"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "15/04/1997",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about topotecan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.